I Monster Bugs I
A charge made during a recent meeting in Chicago of the American Association for the Advancement of Science that "strains of monster bugs" resu lted from use of DDT during malaria campaigns has been rebutted by WHO.
Where resistance to insecticides developed "this was mainly due to their widespread use in agricu lture -in areas where there was intensive agricultural exploitation. involving aeria l spraying of crops -a nd not to the limited amount used in malaria control operations", says Dr Hakan Hellberg, until recently Director of WHO's Division of Public Information and Education for Hea lth.
WHO launched a worldwide malaria eradication programme in the mid-1950s on the basis of successes achieved in Europe, the southern United States. and areas of a number of tropical countries.
By 1968 the number of people living in areas free of malaria increased from an estimated 316 million to 997 million, and mortality declined from 2.5 million to under one million yearly. In India alone. the death rate dropped from 75,000 to 16,000 -probably the sing le most significant indication of the programme's success.
"Hopes were high that malaria cou ld be conquered before resistance appea red," Dr Hellberg says, "hopes which. with hindsight. are easy to criticise". • • •
Smoke-Free Work Sites Growing World-wide
The impetus to ban. or to curb, smoking at work sites and public places. is picking up momentum-in the United States particularly, but elsewhere as well. Among recent developments :
• United States. Th e Federal Government, the employer of 2.3 million people, has ordered all departments to provide a "reasonably smoke-free environm ent" on the job. in essence decreeing that smoking is now forbidden everywhere except where it is express ly permitted .
New York State has passed laws-considered the toughest in the country -against public smoking in such places as "indoor arenas. schools and auditoriums. club houses and court houses. gymnasiums. health clubs. rest rooms. stores. banks. hospitals and movie theatres". according to the New York Times .
In banning smoking , the prestigious Mayo Clinic in Rochester. Minnesota has told its 14,000 workers that "to permit smoking would be inconsistent with ou r leadership role in health".
And, at a new community hospital opened recently in Wentzville, Missouri, smokers need not apply for employment. the management said.
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• Australia. 1 March 1988 has been designated as the target date for smoke-free offices throughout the government.
• Belgium.
King Baudouin has signed into law a ban on smoking in most enclosed public places -s uch as schools. hospitals. rest homes. railroad stations and cu ltura l and sports centres -effective from 1 Septembe r 1987.
The law provides for fines of up to 18,000 Belgian francs ($480) for vio lators.
• Peru. The country has banned smoki ng, as from December 1986, in all offices of the Ministry of Hea lth .
• Singapore. The country has not only banned smoking in public places but also in private offices that share a common air-conditioning system with othe r offices.
Now it has launched a campaign aimed at making Singapore "a nation of non smokers" based on television spots aimed at overcoming the public's shyness about complaining about smoking, and on a campaign song that says:
" " lt is my belief." he adds "that oral rehydration-that remarkable and relatively new tool for the treatment of diarrhoea! diseases -will also be rarely used at the turn of the century. Even family planning will be aided by vaccines."
Among prospects are two vaccines against malaria, one genetica lly engineered. and the other synthet ic. as a result of work in Australia and Sweden. which are "about to undergo their first testing in man"; as we ll as vaccines against schistosomiasis. or snai l fever; aga in st leprosy, now being tested in Venezuela; and against hepatitis B.
Although hepatitis B vaccines. based on techniques of genetic engineering, are being produced by "at least seven different manufacturers." he says, "a cheaper technique for producing the vaccine from plasma has been developed by the New York Blood Center. lt is being made in Korea at a cost of approximately $1 a dose".
According to another participant, Dr Ralph Henderson. Director of WHO's Expanded Programme on Immunization:
"Progress in biotechnology makes it certain we will get improved vaccines for six children's diseases -meas les. tetanus. whooping cough, pol io. diphtheria, and tuberculosis."
While saying that "we would certain ly welcome vaccines that ca use fewer side effects. that are less sensitive to heat. and that can be used with only one dose. and be given any time from birth," the task today, he warned, " is to immunize with the "old" vaccines and thus protect chi ldren .
" We need to comp lete this ta sk without delay," he states, "for each day that passes condemns more than 9.000 children to needless death."
• wHo Found IUDs 'Safe, Effective, And Reliable' Intrauterine devices are "safe, effective and reliable" as a method of contraception, according to a group of experts from 13 countries. Meeting recently under the auspices of WHO to evaluate that method of contraception, they add, however, that "careful patient selection is essential for IUD use.
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Developed about three decades ago, IUDs are estimated today to be the choice of contraception for over 60 million women throughout the world.
However, lawsuits have been taken out against manufacturers, notably in the United States because IUD use has been linked to an increased risk of pelvic inflammatory disease, and to infertility.
Two manufacturers have, as a result, discontinued production of IUDs, which in turn has "triggered off a worldwide chain reaction of concern", the experts say.
However, "the risk of pelvic inflammatory diseases from IUD use is much lower than that was previously thought", is "over-estimated," and "is apparently limited to the first four months after the insertion of the device," they add.
While noting "with regret", the withdrawal of the Lippes Loop, Copper 7, and Copper T 200 -despite approval of use by the US Food and Drug Administration -from the. US market, the experts point out that new copper devices-such as TCu220C, TCu380A Ag, and Nova T-are proving to be significantly better in preventing pregnancy than the earlier copper devices.
In addition, "the effective life of the new copper devices is at least five years, and thus they can be safely left in place," they state.
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